Virtu Financial’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-16,878
| Closed | -$302K | – | 2030 |
|
2025
Q1 | $302K | Buy |
16,878
+16,239
| +2,541% | +$291K | 0.02% | 669 |
|
2024
Q4 | $21K | Sell |
639
-723
| -53% | -$23.8K | ﹤0.01% | 1292 |
|
2024
Q3 | $20K | Buy |
+1,362
| New | +$20K | ﹤0.01% | 1128 |
|
2024
Q2 | – | Sell |
-7
| Closed | -$4K | – | 1881 |
|
2024
Q1 | $4K | Buy |
+7
| New | +$4K | ﹤0.01% | 1303 |
|
2023
Q4 | – | Sell |
-21
| Closed | -$37K | – | 2004 |
|
2023
Q3 | $37K | Buy |
+21
| New | +$37K | ﹤0.01% | 936 |
|
2023
Q2 | – | Sell |
-3
| Closed | -$35K | – | 2042 |
|
2023
Q1 | $35K | Sell |
3
-6
| -67% | -$70K | ﹤0.01% | 1157 |
|
2022
Q4 | $73K | Buy |
9
+3
| +50% | +$24.3K | 0.01% | 1018 |
|
2022
Q3 | $69K | Buy |
+6
| New | +$69K | 0.01% | 1144 |
|
2022
Q1 | – | Hold |
0
| – | -$110K | – | 2035 |
|
2021
Q4 | – | Sell |
-1
| Closed | -$441K | – | 1091 |
|
2021
Q3 | $441K | Buy |
+1
| New | +$441K | 0.04% | 524 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 677 |
|
2020
Q4 | – | Hold |
0
| – | -$79K | – | 1799 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 754 |
|
2018
Q4 | – | Hold |
0
| – | -$13K | – | 1981 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 1427 |
|
2018
Q2 | – | Hold |
0
| – | -$57K | – | 2496 |
|
2018
Q1 | – | Hold |
0
| – | -$78K | – | 1688 |
|
2017
Q4 | – | Hold |
0
| – | -$56K | – | 1979 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 2208 |
|